Le Lézard
Classified in: Covid-19 virus
Subjects: CPN, AVO

Missick Calls on Brouk to Follow Biden's Lead and Pull Negative Trump Themed Content


ROCHESTER, N.Y., Oct. 5, 2020 /PRNewswire/ -- Chris Missick, candidate for State Senate in New York's 55th District, has called on his opponent to follow the leadership of Vice President Biden.

"Since we began this campaign we have stayed away from Presidential politics because this race is about your house not the White House. My opponent, Samra Brouk and Democrats more generally, have taken the opposite approach. They use every opportunity to try to make every race about the President in their negative ads and flyers. Joe Biden has now taken down all of his negative ads against President Trump while he is treated for the Coronavirus. That's a classy move and one Samra Brouk and New York Democrats should follow. It's in poor taste to continue to use attack ads and mailers mentioning the President while he fights to regain his health from Covid-19 at Walter Reed Medical Center. I call on Samra Brouk and all New York Democrats to stop these negative attacks immediately."

Christopher Missick is a veteran of Operation Iraqi Freedom, a lawyer, and a small businesses owner. He and his family and friends have experienced a barrage of unfounded negative attacks from his opponent and New York Senate Democrats.  He owns and operates a vineyard and winery in the Finger Lakes region of New York. To read more about Chris Missick's platform go to votemissick.com.

Contact:
Erin Loftus 
585-478-2858

SOURCE Missick for Senate


These press releases may also interest you

at 14:45
The "Yeast - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Yeast Market to Reach $11.6 Billion by 2030 The global market for Yeast estimated at US$6.2 Billion in the year 2023, is projected to reach...

at 14:15
Natuzzi chooses the stage of two among the most relevant global furniture events, High Point Market in North Carolina, and the Design Week in Milan, to unveil the dense program of events and projects that will mark the calendar of its 65th...

at 12:50
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation ("QuidelOrtho"...

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...



News published on and distributed by: